MIYAKAWA Yoshitaka

ミヤカワヨシタカ | MIYAKAWA Yoshitaka

Affiliation and department：
Job title： Professor

Research field (1)： Hematology and oncology

Research theme for competitive and other funds (4)：

Papers (130)：

宮川義隆. 慢性肝疾患における血小板減少のメカニズム. Thrombosis Medicine. 2024. 14. Suppl 1. 8-12
宮川義隆. トロンボポエチン受容体作動薬. 小児科診療. 2024. 87. 5. 587-590
宮川義隆. 後天性血栓性血小板減少性紫斑病(TTP)の最新治療. Medical practice. 2024. 41. 482-484
Matsumoto M, Miyakawa Y, Kokame K, et al. Diagnositic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023. Int J Hematol. 2023. 118. 529-546
宮川義隆. 特発性血小板減少性紫斑病の分子標的薬. 日本医師会雑誌. 2023. 152. 7. 798-799

ｍore...

Patents (2)：

Books (12)：

ｍore...

Lectures and oral presentations (72)：

Safety and efficacy of efgartigmod in primary immune thrombocytopenia: ADVANCE IV+ 2 year analysis
(The XXVIII National Cogress of SISET 2024)
Post hoc analysis of ADAMTS13 activity and inhibitors in a phase 2/3 sutdy in Japanese patients with iTTP treated with caplacizumab
(International Society of Thrombosis and Hemostasis 2024 Congress 2024)
Time to platelet count response afetr IV efgartigimod in primary ITP
(第46回日本血栓止血学会が宇術集会 2024)
Basic characteristics of adult patients with previously treated immune thrombocytopenia enrolled in LUNA3 phase 3 placebo-controlled study of rilzabrutinib, an oral bruton tyrosine kinase inhibitor
(The annual meeting of European Hematolgy Association 2024)
Inhibition of complement C1s with sutimlimab in patients with cold agglutinin disease (CAD): 2 year follow up from the CARDINAL study
(FADOI学術集会 2023)

ｍore...

Works (1)：

Education (1)：

Professional career (1)：

Committee career (1)：

Awards (1)：

Association Membership(s) (2)：

日本血液学会 , 日本血栓止血学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page